Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Clin Gastroenterol Hepatol. 2015 Jul 18;14(1):124–131.e1. doi: 10.1016/j.cgh.2015.07.019

Table 4.

Association between etiologic risk factors and risk of HCC in absence of cirrhosis – Results of logistic regression analysis examining two models (model 1 contains NAFLD, model 2 contains metabolic syndrome)

Model 1 Model 2
Variable n Unadjusted OR (95% CI) * Adjusted OR (95% CI) Variable Unadjusted OR (95% CI) * Adjusted OR (95% CI)
Etiology Etiology
  HCV 952 1.0 1.0 HCV 1.0 1.0
 NAFLD 107 5.4 (3.4–8.5) 3.9 (2.1–7.3) Metabolic syndrome 5.0 (3.1–7.8) 3.4 (1.9–6.4)
 Alcohol abuse 280 2.6 (1.8–3.8) 2.5 (1.6–3.9) Alcohol abuse 2.6 (1.8–3.8) 2.5 (1.5–3.9)
  HBV 15 1.6 (0.4–7.1) 1.3 (0.2–7.2) HBV 1.6 (0.4–7.1) 1.3 (0.2–7.2)
Idiopathic 41 4.7 (2.4–9.5) 3.6 (1.6–8.3) Idiopathic 6.0 (3.0–11.9) 5.1 (2.2–11.7)
Age 139 5 1.0 (1.0–1.1) 1.0 (1.0–1.1)
Race
  White 829 1.0 1.0
  Black 362 2.2 (1.5–3.4) 2.2 (1.5–3.4)
 Hispanic 172 0.4 (0.2–0.7) 0.4 (0.2–0.7)
  Others 32 0.9 (0.2–3.4) 0.9 (0.2–3.4)
BCLC Stage
   A 188 1.0 1.0
   B 328 2.9 (1.4–5.8) 2.9 (1.4–5.9)
   C 527 2.5 (1.3–5.2) 2.6 (1.3–5.2)
   D 246 1.2 (0.5–2.9) 1.2 (0.5–2.9)
Unknown 106 2.5 (1.0–6.0) 2.5 (1.0–2.9)
MELD score
   < 10 551 1.0 1.0
  10–19.9 641 0.2 (0.1–0.3) 0.2 (0.1–0.3)
   20+ 73 0.1 (0.0–0.5) 0.1 (0.0–0.5)
 Unknown 130 0.7 (0.4–1.2) 0.7 (0.4–1.3)
AFP
   <20 516 1.0 1.0
   20+ 780 0.8 (0.5–1.2) 0.8 (0.5–1.2)
 Unknown 99 1.6 (0.9–2.8) 1.6 (0.9–2.8)
PVT
  Absent 111 3 1.0 1.0
  Present 241 0.6 (0.3–1.1) 0.6 (0.3–1.1)
Unknown 41 2.3 (1.1–4.9)
*

Adjusted for age, race, BCLC stage, MELD score, AFP and portal vein thrombus